Methotrexate in the Treatment of Chronic Idiopathic Urticaria
NCT01960283
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
83
Enrollment
OTHER
Sponsor class
Conditions
Chronic Urticaria
Interventions
DRUG:
Methotrexate (Novatrex ®) + anti-H1
DRUG:
Placebo + anti-H1
Sponsor
University Hospital, Tours